Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.96 USD | -1.48% | -6.85% | -0.58% |
May. 13 | Liquidia Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 01 | Liquidia Says US FDA Cleared to Approve Yutrepia to Treat Hypertension | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.58% | 914M | |
+31.10% | 588B | |
-3.42% | 364B | |
+18.02% | 326B | |
+4.27% | 285B | |
+14.77% | 239B | |
+10.20% | 210B | |
-6.91% | 200B | |
+8.12% | 167B | |
-1.42% | 161B |
- Stock Market
- Equities
- LQDA Stock
- News Liquidia Corporation
- Wedbush Cuts Price Target on Liquidia Technologies to $4 From $6, Citing Tyvaso Market Penetration Estimates, Maintains Neutral Rating